Transfection Reagent And Equipment Market Size, Share, & Trends Report

Transfection Reagent And Equipment Market Size, Share, & Trends Analysis Report By Product, By Method, By Application (Gene Expression, Protein Production, Cancer Research, Therapeutics), And Segment Forecasts, 2014 - 2022

  • Published Date: May, 2018
  • Base Year for Estimate: 2016
  • Report ID: 978-1-68038-715-5
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 100

Industry Outlook

The global transfection reagent & equipment market size was valued at USD 706.26 million in 2016. It is expected to expand at a CAGR of 7.4% during the forecast period. Development in the field of recombinant technology & proteomics and growing usage of transfection technology by academic researchers are some of the key trends stoking market growth. Introduction of novel reagents to expand transfection usage across various applications is also anticipated to provide an upthrust to the market.

Japan transfection reagent & equipment market

Transfection plays a pivotal role in biomanufacturing by facilitating investigative analysis and bio-authenticity studies for biopharmaceuticals’ regulatory approvals. Hence, with growing popularity of biopharmaceuticals, this technology is likely to witness phenomenal growth in terms of demand as well as sales.

Furthermore, in recent times, the biopharmaceutical industry has witnessed a major patent cliff as several blockbuster biologics are facing patent expiration. Consequently, several companies have begun investing in production of biosimilar alternatives to off-patent biologics to overcome the threat of revenue loss. Hence, this patent cliff threat has significantly benefitted the market by spurring the adoption rate of transfection technology.

Technological advancements pertaining to introduction of advanced techniques for stable and transient transfection with negligible off-target effects are projected to aurgur well for the market during the forecast period. For example, Life Technologies has launched Lipofectamine, lipid-based formulations for nucleic acid delivery, which enhances cell viability and reproducibility during transfection process of hard to transfect cell lines by virtue of optimization in different steps of transfection.

Furthermore, gradual emergence of nanoscience and its widespread application in biomedical research is poised to support the growth of the market. For instance, ongoing developments in drug delivery systems using nanoparticles are estimated to positively impact the market.

Product Insights

Reagents used for transfection majorly include stem cell transfection kits, siRNA transfection kits, transfection buffers, and transfection optimization kits. Different methods of transfection involve use of different reagents, thus generating substantial revenue in the segment.

The reagents segment dominated the market in terms of revenue. This segment is projected to gain significant share over the forecast period owing to increasing commercial adoption rates of these reagents.

Transfection equipment includes electroporation and electro fusion systems. Rapidly growing volume of genomics-based R&D initiatives and introduction of user-friendly products such as portable DNA sequencers are poised to propel the transfection reagent & equipment market during the forecast period.

Owing to presence of expensive laser-based equipment used for different transfection methods such as laserfection or optoinjection are estimated to boost the growth of the equipment segment.

Method Insight

Electroporation accounted for the leading revenue share in 2016, closely followed by liposomal transfection and particle bombardment. Wide portfolios for a range of electroporation solutions offered by major as well as emerging players are stimulating the growth of the segment. Moreover, several advantages offered by the method such as ease of use, variability, and timeliness are escalating the growth of the segment.

With significant share in 2016, the liposomes segment is anticipated to post noteworthy CAGR during the forecast period. Ongoing development of lipofection to enhance the efficiency of in-vivo transfection is likely to bolster the adoption of this method.

Application Insights

Revenue generation from transfection applications is expected to rise substantially owing to high procedure volumes and presence of a relatively larger number of R&D programs, thereby leading to market progress.

Global transfection reagent & equipment market

The applications of transfection reagents and equipment reviewed in the report are gene expression studies, protein production, transgenic model generation, therapeutic delivery, biomedical research, and cancer research. Gene expression studies were the most prominent application segment in 2016.

Expansion of genomic data pool and growing emphasis on translation of genomic information in clinical workflow are leading to a considerable share of this segment. Presence of a substantial number of ongoing research projects that aim at in-depth investigation of key mechanism, which underlie chromosomal anomalies, is also supplementing the growth of the segment.

Regional Insights

North America was the leading revenue contributor in the market in 2016 owing to presence of well-established biopharmaceutical and genomic industries in the region. High usage of transfection technologies has been witnessed within genetic, cytological, and oncology research-based entities. Presence of prominent companies that offer a wide range of solutions to serve various end users in the region is also contributing to the growth of the regional market.

Asia-Pacific is estimated to register the fastest growth during the forecast period. Significant growth in the number of biopharmaceutical & clinical R&D programs, increasing medical research expenditure, and rising awareness regarding cytological and proteomic expressions are some of the key trends driving the regional market.

Transfection Reagent & Equipment Market Share Insights

Thermo Fisher Scientific Inc.; Promega Corporation; QIAGEN; Mirus Bio LLC; Merck KGaA; and Bio-Rad Laboratories, Inc. are some of some key participants in the market. These companies are making significant attempts to maintain their prominence in the market over the coming years.

Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd; and Promega Corporation are recognized as prominent players owing to their extensive product portfolio and revenue generation in the market. These companies are continuously expanding their business across the world to maintain their dominance in the market.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2022

Market representation

Revenue in USD Million and CAGR from 2017 to 2022

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, Germany, U.K., China, Japan, Brazil, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5-analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of industry trends in each of the sub segments from 2014 to 2022. For the purpose of this study, Grand View Research has segmented the global transfection reagent & equipment market report on the basis of product, method, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2022)

    • Reagents

    • Equipment

  • Method Outlook (Revenue, USD Million, 2014 - 2022)

    • Electroporation

    • Liposomes

    • Particle Bombardment

    • Microinjection

    • Adenoviral Vectors

    • Direct Microinjection

    • Calcium phosphate

    • DEAE - dextran

    • Magnetic Beads

    • Activated Dendrimers

    • Laserfection

  • Application Outlook (Revenue, USD Million, 2014 - 2022)

    • Gene Expression Studies

    • Protein Production

    • Transgenic Models

    • Therapeutic Delivery

    • Cancer Research

    • Biomedical Research

  • Regional Outlook (Revenue, USD Million, 2014 - 2022)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,450
Multi User (2-5) - $6,450
BI Library Access - $8,450

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified